Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × Injections × Clear all

NCT06612151 2025-02-11

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma